Orthofix Medical (OFIX) Change in Receivables (2010 - 2026)

Orthofix Medical has disclosed Change in Receivables across 16 years of filings, most recently posting $3.0 million for Q1 2026.

• Quarterly Change in Receivables rose 224.59% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (down 12.99% YoY) and the FY2025 annual result came in at $1.6 million, down 83.38% from the prior year.
• Change in Receivables retreated to $3.0 million in Q1 2026, from $4.7 million in the prior quarter.
• Over five years, Change in Receivables peaked at $13.3 million in Q4 2023 and troughed at -$5.4 million in Q1 2022.
• A 5-year average of $1.8 million and a median of $103000.0 in 2024 frame the typical range for Change in Receivables.
• Annual changes were most pronounced in 2023 — Change in Receivables jumped 1143.63% — and 2025, when it tumbled 2731.07%.
• Tracing OFIX's Change in Receivables over 5 years: stood at $6.8 million in 2022, then soared by 96.33% to $13.3 million in 2023, then slipped by 18.73% to $10.8 million in 2024, then slumped by 56.46% to $4.7 million in 2025, then sank by 37.12% to $3.0 million in 2026.
• Business Quant data shows OFIX's Change in Receivables at $3.0 million in Q1 2026, $4.7 million in Q4 2025, and $2.0 million in Q3 2025.